Brief: Aroa Biosurgery Says FY24 Product Revenue Guidance Maintained At NZ$72-75 Mln

Aroa Biosurgery

31/10/2023 24:50

Oct 31 (Reuters) - Aroa Biosurgery Ltd  ARX.AX :
    * FY24 PRODUCT REVENUE GUIDANCE MAINTAINED AT NZ$72-75
MILLION
    * FY24 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED AT
NZ$1-2
MILLION

Source text for Eikon:  ID:nASX9t5F2B 
Further company coverage:  ARX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))